Table 1 Clinical characteristics associated with blood MAIT cell frequency using linear regression
From: Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver
Variable | Regression coefficient | 95% CI | p | |
|---|---|---|---|---|
Lower bound | Higher bound | |||
a. Univariate analysis | ||||
Among the entire population | ||||
Age | −0.034 | −0.057 | −0.011 | <0.01 |
Male sex | −0.538 | −1.16 | 0.084 | 0.09 |
Cirrhosis | −1.918 | −2.426 | −1.41 | <0.01 |
Among patients with cirrhosis | ||||
Alcohol-related cirrhosis | −0.187 | −0.63 | 0.256 | 0.40 |
NASH-related cirrhosis | −0.04 | −0.502 | 0.421 | 0.86 |
Child–Pugh score | 0.004 | −0.057 | 0.064 | 0.90 |
MELD score | 0.001 | −0.021 | 0.024 | 0.89 |
Ascites | 0.019 | −0.331 | 0.369 | 0.91 |
Encephalopathy | 0.188 | −0.217 | 0.594 | 0.36 |
Chronic antibiotic prophylaxis (norfloxacin and/or rifaximin) (%) | 0.582 | 0.093 | 1.072 | 0.02 |
Beta-blockers | −0.016 | −0.08 | 0.049 | 0.63 |
b. Bivariate analysis | ||||
Among the entire population | ||||
Age | −0.034 | −0.057 | −0.011 | <0.01 |
Cirrhosis | −1.52 | −2.206 | −0.834 | <0.01 |
Among patients with cirrhosis | ||||
Age | 0.012 | −0.003 | 0.028 | 0.11 |
Chronic antibiotic prophylaxis (norfloxacin and/or rifaximin) | 0.55 | 0.067 | 1.033 | 0.03 |